Pepdox
Studies
Peptides
Calculator
Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial. | Pepdox
Home
/
Search
/
PMID 42035776
Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial.
Lancet (London, England)
2026
PMID: 42035776
View on PubMed
DOI: 10.1016/S0140-6736(26)00255-2
Semaglutide
Authors
Mangalesh, Sridhar; Theodoropoulos, Panagiotis; Chi, Kuan-Yu; Nanna, Michael G